Measuring Quality of Life in the Speakers with Dysarthria: Reliability and Validity of the Persian Version of the Qol-Dys
Medical Journal of The Islamic Republic of Iran · 25.11.2025
DOI: 10.47176/mjiri.39.139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Journal of The Islamic Republic of Iran, online erschienen am 25.11.2025. Verfasst von Golnoosh Abaeian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Speech Therapy Department, Rehabilitation Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Speech Therapy Department, Rehabilitation Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Department of Communication Sciences and Disorders, University of Wisconsin-River Falls, River Falls, Wisconsin, USA.
- Department of Biostatistics and Epidemiology, Faculty of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
ORCID-Profile: Majid Soltani
Zitieren
APA
Abaeian, G., Soltani, M., Moradi, N., Rahimifar, P., & Hesam, S. (2025). Measuring Quality of Life in the Speakers with Dysarthria: Reliability and Validity of the Persian Version of the Qol-Dys. Medical Journal of The Islamic Republic of Iran. https://doi.org/10.47176/mjiri.39.139
Vancouver
Abaeian G, Soltani M, Moradi N, Rahimifar P, Hesam S. Measuring Quality of Life in the Speakers with Dysarthria: Reliability and Validity of the Persian Version of the Qol-Dys. Medical Journal of The Islamic Republic of Iran. 2025. doi:10.47176/mjiri.39.139
BibTeX
@article{Abaeian2025,
author = {Abaeian, Golnoosh and Soltani, Majid and Moradi, Negin and Rahimifar, Parvaneh and Hesam, Saeed},
title = {Measuring Quality of Life in the Speakers with Dysarthria: Reliability and Validity of the Persian Version of the Qol-Dys},
journal = {Medical Journal of The Islamic Republic of Iran},
year = {2025},
doi = {10.47176/mjiri.39.139}
}
EUVIMED